Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» IRIDEX Granted U.S. Patent for MicroPulse™ Technology - A Fine Dose Control Technology Enabling Tissue Sparing Eye Surgeries With Visible Lasers
IRIDEX Granted U.S. Patent for MicroPulse™ Technology - A Fine Dose Control Technology Enabling Tissue Sparing Eye Surgeries With Visible Lasers
IRIDEX Granted U.S. Patent for MicroPulse™ Technology - A Fine Dose Control Technology Enabling Tissue Sparing Eye Surgeries With Visible Lasers
Submitted by
moderatora
on August 18, 2010 - 7:21am
Source:
PR Newswire
News Tags:
Iridex
Headline:
IRIDEX Granted U.S. Patent for MicroPulse™ Technology - A Fine Dose Control Technology Enabling Tissue Sparing Eye Surgeries With Visible Lasers
Do Not Allow Advertisers to Use My Personal information
